Please login to the form below
UCB’s Mark Bodmer elected to BIA board
Will hold the position for a three-year fixed term
UCB's Mark Bodmer has been elected to the board of UK trade body the BioIndustry Association (BIA).
Bodmer is VP, NewMedicines Therapeutics at UCB, having joined the company in 2012 as head of immunology.
As a board member of the BIA Bodmer will play a role in shaping the policy environment of the UK biotech industry. He will hold the role for three years, starting in January 2015.
Prior to joining UCB Bodmer served as senior VP of immunoinflammation, medicines discovery and development at GlaxoSmithKline.
His background also includes CEO appointments at three start-ups from 1996 to 2007: Hexagen, Lorantis and Biotica.
Featured jobs
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
New Business Director - PR
-
Competitive Salary and benefits
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
Senior Account Manager
-
Negotiable
-
Associate Medical Director
-
Highly Competitive
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
-
Medical/ Scientific Director
-
Salary TBC
-
Senior Medical Writer
-
Competitive Salary
-
Medical Writers
-
Competitive Salary and Benefits
-
Account Director
-
Excellent benefits
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Account Director
-
£48, 000 - £60, 000
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Senior Medical Writer
-
Great salary and benefits
-
Associate Director
-
£75, 000-90, 000
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
Subscribe to our email news alerts
- The handover: Pfizer reshapes itself for a new era
- AbbVie sues NHS England over hep C procurement
- GSK among businesses wooed as Brexit reckoning nears
- BioMarin eyes 2019 FDA filing for haemophilia A gene therapy
- The handover: Pfizer reshapes itself for a new era
- Novartis: pipeline will generate 60 filings in three years
- Artificial Intelligence In Healthcare Market to Witness Exponential Growth by 2027
- Breathing Exercise Devices Market Intelligence Report Offers Growth Prospects
- Micro-CT Scanners Market 10-Year Market Forecast and Trends Analysis Research Report
- Next Generation Infusion Pump Market Healthy Pace throughout the Forecast during 2017 – 2027
- Wireless Brain Sensors Market Intelligence Report Offers Growth Prospects
- MRI Guided Neurosurgical Ablation Market is Projected to Expand at a CAGR of 4.9% During the Forecast Period 2018–2028 and Reach US$ 216.3 Mn By the End of 2028
PMHub
Apex.co.uk Conferences, Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
